Diagnostic accuracy of covid-19 rapid antigen tests with unsupervised self-sampling in people with symptoms in the omicron period: cross sectional study
Self-sampling, symptoms and the reason for testing can change the performance measured in a diagnostic study.
What the paper explores
The investigators evaluated unsupervised rapid antigen self-tests among symptomatic people during the Omicron period in the Netherlands. Results varied with the sampling approach and with whether participants were already confirming a positive self-test. That recruitment context is an important part of interpreting the reported sensitivity.
How to interpret the evidence
This was a diagnostic accuracy study in a particular epidemic and recruitment setting. Its results should not be transferred directly to a different population. A published correction is linked below; consult the corrected article before using exact values.
Questions for MedTech teams
Document who enters the study, why they seek testing and how specimens are collected. Those details help explain what a reported performance estimate actually represents.
Sources & further reading
Read original paperDOI: 10.1136/bmj-2022-071215
Bibliographic record and abstract on PubMedPublished correction (PMC record)This is a short editorial reading note on external research. The original research is attributed to its authors and does not represent an HMC study, product validation or regulatory determination.
